{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:45:07Z","timestamp":1777531507351,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.revmed.2013.02.022","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T21:20:08Z","timestamp":1363641608000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Maladie de Rendu-Osler"],"prefix":"10.1016","volume":"35","author":[{"given":"P.","family":"Duffau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lazarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.02.022_bib0005","first-page":"3","article-title":"Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence","volume":"44","author":"Bideau","year":"1989","journal-title":"Popul"},{"key":"10.1016\/j.revmed.2013.02.022_bib0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ejhg.2008.3","article-title":"Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1\u00a0mutations in French and Italian patients","volume":"16","author":"Lesca","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1\u00a0gene in hereditary haemorrhagic telangiectasia type 2","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0025","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia-associated with mutations in MADH4 (Smad4)","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0030","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.febslet.2012.05.028","article-title":"Structural studies of the TGF-betas and their receptors\u00a0\u2013\u00a0insights into evolution of the TGF-beta superfamily","volume":"586","author":"Hinck","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.revmed.2013.02.022_bib0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","article-title":"Recent advances in BMP receptor signaling","volume":"20","author":"Sieber","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.revmed.2013.02.022_bib0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0002-9440(10)64960-7","article-title":"Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1","volume":"156","author":"Bourdeau","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0045","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2010-03-276881","article-title":"Functional analysis of the BMP9\u00a0response of ALK1\u00a0mutants from HHT2\u00a0patients: a diagnostic tool for novel ACVRL1\u00a0mutations","volume":"116","author":"Ricard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.02.022_bib0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/81634","article-title":"Arteriovenous malformations in mice lacking activin receptor-like kinase-1","volume":"26","author":"Urness","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0012-1606(03)00158-1","article-title":"Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGF-beta coreceptor","volume":"261","author":"Sorensen","year":"2003","journal-title":"Dev Biol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","article-title":"A murine model of hereditary hemorrhagic telangiectasia","volume":"104","author":"Bourdeau","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2013.02.022_bib0065","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1242\/dev.129.12.3009","article-title":"Disruption of ACVRL1\u00a0increases endothelial cell number in zebrafish cranial vessels","volume":"129","author":"Roman","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.revmed.2013.02.022_bib0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jmg.40.8.585","article-title":"Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1\u00a0mutations","volume":"40","author":"Berg","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.2005.035451","article-title":"Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia","volume":"43","author":"Letteboer","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","article-title":"Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network","volume":"9","author":"Lesca","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.revmed.2013.02.022_bib0085","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0002-9440(10)64673-1","article-title":"Potential role of modifier genes influencing transforming growth factor-beta1\u00a0levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia","volume":"158","author":"Bourdeau","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0090","first-page":"3487","article-title":"Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia","volume":"119","author":"Park","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2013.02.022_bib0095","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of BMP9\u00a0and BMP10\u00a0as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells","volume":"109","author":"David","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.02.022_bib0100","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1182\/blood.V100.13.4495","article-title":"Activin receptor-like kinase 1\u00a0is implicated in the maturation phase of angiogenesis","volume":"100","author":"Lamouille","year":"2002","journal-title":"Blood"},{"issue":"Pt 6","key":"10.1016\/j.revmed.2013.02.022_bib0105","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1242\/jcs.002949","article-title":"BMP-9\u00a0signals via ALK1\u00a0and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis","volume":"120","author":"Scharpfenecker","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.revmed.2013.02.022_bib0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","article-title":"Bone morphogenetic protein-9\u00a0is a circulating vascular quiescence factor","volume":"102","author":"David","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.revmed.2013.02.022_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.revmed.2013.02.022_bib0120","first-page":"407","article-title":"Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia: analysis of distribution and symptoms","volume":"14","author":"Folz","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1164\/ajrccm.158.2.9711041","article-title":"Pulmonary arteriovenous malformations. A state of the art review","volume":"158","author":"Gossage","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2013.02.022_bib0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4065\/74.7.671","article-title":"Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982\u20131997","volume":"74","author":"Swanson","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2013.02.022_bib0135","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/thx.54.8.714","article-title":"Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms","volume":"54","author":"Shovlin","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2013.02.022_bib0140","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","article-title":"Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1\u00a0mutation carriers","volume":"5","author":"Sabba","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2013.02.022_bib0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/511645","article-title":"Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association","volume":"44","author":"Dupuis-Girod","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2013.02.022_bib0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.06-2356","article-title":"Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT","volume":"132","author":"Zukotynski","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2013.02.022_bib0155","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiology.191.3.8184042","article-title":"Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT","volume":"191","author":"Remy","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2013.02.022_bib0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2007.12.022","article-title":"Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs. multislice computed tomography study","volume":"48","author":"Buonamico","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0165","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations","volume":"26","author":"Buscarini","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.revmed.2013.02.022_bib0170","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/01.STR.32.4.877","article-title":"Cerebrovascular manifestations in 321\u00a0cases of hereditary hemorrhagic telangiectasia","volume":"32","author":"Maher","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.revmed.2013.02.022_bib0175","first-page":"477","article-title":"MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations","volume":"19","author":"Fulbright","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00234-005-1390-8","article-title":"Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50\u00a0consecutive patients aged 1\u00a0day\u201360\u00a0years","volume":"47","author":"Krings","year":"2005","journal-title":"Neuroradiology"},{"key":"10.1016\/j.revmed.2013.02.022_bib0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3171\/jns.2000.92.5.0779","article-title":"Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia","volume":"92","author":"Willemse","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2013.02.022_bib0190","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1055\/s-2004-826045","article-title":"Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study","volume":"36","author":"Ingrosso","year":"2004","journal-title":"Endoscopy"},{"key":"10.1016\/j.revmed.2013.02.022_bib0195","first-page":"40","article-title":"Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease","volume":"43","author":"Folz","year":"2005","journal-title":"Rhinology"},{"key":"10.1016\/j.revmed.2013.02.022_bib0200","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/138161206776361255","article-title":"Treatment of recurrent epistaxis in HHT","volume":"12","author":"Geisthoff","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.revmed.2013.02.022_bib0205","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00004836-198812000-00022","article-title":"Estrogen-progesterone treatment of Osler-Weber-Rendu disease","volume":"10","author":"Van Cutsem","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0210","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM200109203451216","article-title":"Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia","volume":"345","author":"Sabba","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2013.02.022_bib0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2013.02.022_bib0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14764170601091687","article-title":"Treatment of cutaneous and mucosal telangiectases in hereditary hemorrhagic telangiectasia: report of three cases","volume":"9","author":"Fernandez-Jorge","year":"2007","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.revmed.2013.02.022_bib0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bdj.2008.978","article-title":"Post-NICE 2008: antibiotic prophylaxis prior to dental procedures for patients with pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia","volume":"205","author":"Shovlin","year":"2008","journal-title":"Br Dent J"},{"issue":"3\u00a0Pt 1","key":"10.1016\/j.revmed.2013.02.022_bib0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0221-0363(07)89833-7","article-title":"Embolisation des malformations art\u00e9rio-veineuses pulmonaires localis\u00e9es de l\u2019adulte","volume":"88","author":"Pelage","year":"2007","journal-title":"J Radiol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0235","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/ajrccm\/142.2.420","article-title":"Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations","volume":"142","author":"Chilvers","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.revmed.2013.02.022_bib0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0168-8278(95)80455-2","article-title":"Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia","volume":"22","author":"Bauer","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.revmed.2013.02.022_bib0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/lt.21990","article-title":"Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study","volume":"16","author":"Dupuis-Girod","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.revmed.2013.02.022_bib0250","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3171\/jns.1990.73.3.0387","article-title":"The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment","volume":"73","author":"Ondra","year":"1990","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2013.02.022_bib0255","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/lary.23303","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose","volume":"122","author":"Dheyauldeen","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.revmed.2013.02.022_bib0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MAJ.0b013e3182429866","article-title":"Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab","volume":"343","author":"Fleagle","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.revmed.2013.02.022_bib0265","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/lary.21415","article-title":"Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis","volume":"121","author":"Karnezis","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.revmed.2013.02.022_bib0270","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:14Z","timestamp":1759336334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0248866313000684"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.022","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladie de Rendu-Osler","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}